Quantum Biopharma Ltd.https://investorshangout.com/Quantum-Biopharma-Ltd-QNTM-68772/en-usSat, 07 Nov 2026 20:11:29 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Files Supplement to Shareholder Meetinghttps://investorshangout.com/post/view?id=6851612https://investorshangout.com/post/view?id=6851612Fri, 06 Nov 2026 20:05:36 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Broad Strategy Anchored by Science, Disciplined Grhttps://investorshangout.com/post/view?id=6851328https://investorshangout.com/post/view?id=6851328Wed, 04 Nov 2026 20:28:15 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Earlhttps://investorshangout.com/post/view?id=6851004https://investorshangout.com/post/view?id=6851004Mon, 02 Nov 2026 20:57:23 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Taps Thermo Fisher’s Clinical Research https://investorshangout.com/post/view?id=6850732https://investorshangout.com/post/view?id=6850732Fri, 30 Oct 2026 19:21:14 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in Men’s Fitness Article Examihttps://investorshangout.com/post/view?id=6849002https://investorshangout.com/post/view?id=6849002Mon, 19 Oct 2026 20:20:15 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains FDA Clearance to Test Distinct Aphttps://investorshangout.com/post/view?id=6848403https://investorshangout.com/post/view?id=6848403Wed, 14 Oct 2026 19:59:15 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launchttps://investorshangout.com/post/view?id=6847574https://investorshangout.com/post/view?id=6847574Wed, 07 Oct 2026 20:43:14 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Luchttps://investorshangout.com/post/view?id=6847418https://investorshangout.com/post/view?id=6847418Tue, 06 Oct 2026 20:54:10 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Co-Founder Discusses Lucid-https://investorshangout.com/post/view?id=6846743https://investorshangout.com/post/view?id=6846743Wed, 30 Sep 2026 21:34:43 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testhttps://investorshangout.com/post/view?id=6845950https://investorshangout.com/post/view?id=6845950Thu, 24 Sep 2026 20:24:18 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatmentshttps://investorshangout.com/post/view?id=6845789https://investorshangout.com/post/view?id=6845789Wed, 23 Sep 2026 21:22:34 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatmentshttps://investorshangout.com/post/view?id=6845605https://investorshangout.com/post/view?id=6845605Tue, 22 Sep 2026 20:34:24 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiathttps://investorshangout.com/post/view?id=6844979https://investorshangout.com/post/view?id=6844979Thu, 17 Sep 2026 21:38:02 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingshttps://investorshangout.com/post/view?id=6844685https://investorshangout.com/post/view?id=6844685Tue, 15 Sep 2026 20:28:46 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in NetworkNewsAudio APR Highlihttps://investorshangout.com/post/view?id=6844511https://investorshangout.com/post/view?id=6844511Mon, 14 Sep 2026 21:08:53 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Luchttps://investorshangout.com/post/view?id=6844202https://investorshangout.com/post/view?id=6844202Fri, 11 Sep 2026 21:43:59 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial https://investorshangout.com/post/view?id=6844020https://investorshangout.com/post/view?id=6844020Thu, 10 Sep 2026 19:58:46 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Edithttps://investorshangout.com/post/view?id=6843869https://investorshangout.com/post/view?id=6843869Wed, 09 Sep 2026 19:45:58 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Fhttps://investorshangout.com/post/view?id=6843731https://investorshangout.com/post/view?id=6843731Tue, 08 Sep 2026 20:23:44 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucidhttps://investorshangout.com/post/view?id=6842754https://investorshangout.com/post/view?id=6842754Mon, 31 Aug 2026 21:30:37 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS https://investorshangout.com/post/view?id=6842378https://investorshangout.com/post/view?id=6842378Thu, 27 Aug 2026 20:30:35 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigmhttps://investorshangout.com/post/view?id=6841422https://investorshangout.com/post/view?id=6841422Wed, 19 Aug 2026 20:57:16 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Explores Myelin Protection https://investorshangout.com/post/view?id=6841414https://investorshangout.com/post/view?id=6841414Wed, 19 Aug 2026 20:32:53 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, https://investorshangout.com/post/view?id=6840919https://investorshangout.com/post/view?id=6840919Fri, 14 Aug 2026 22:28:05 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rateshttps://investorshangout.com/post/view?id=6840610https://investorshangout.com/post/view?id=6840610Wed, 12 Aug 2026 20:52:09 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Ahttps://investorshangout.com/post/view?id=6840277https://investorshangout.com/post/view?id=6840277Mon, 10 Aug 2026 20:32:21 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approahttps://investorshangout.com/post/view?id=6840075https://investorshangout.com/post/view?id=6840075Fri, 07 Aug 2026 21:36:44 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study withhttps://investorshangout.com/post/view?id=6839346https://investorshangout.com/post/view?id=6839346Fri, 31 Jul 2026 20:47:12 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Executive Outlines Lucid-MShttps://investorshangout.com/post/view?id=6838792https://investorshangout.com/post/view?id=6838792Mon, 27 Jul 2026 21:27:38 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Hits Key Study Milestone as Early MS Imaging Dahttps://investorshangout.com/post/view?id=6838168https://investorshangout.com/post/view?id=6838168Tue, 21 Jul 2026 20:25:10 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorderhttps://investorshangout.com/post/view?id=6838166https://investorshangout.com/post/view?id=6838166Tue, 21 Jul 2026 20:19:52 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Developmenhttps://investorshangout.com/post/view?id=6837527https://investorshangout.com/post/view?id=6837527Tue, 14 Jul 2026 20:55:24 GMTNetworkNewsWire: NetworkNewsBreaks – Why Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’ https://investorshangout.com/post/view?id=6837012https://investorshangout.com/post/view?id=6837012Thu, 09 Jul 2026 21:10:58 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strahttps://investorshangout.com/post/view?id=6836144https://investorshangout.com/post/view?id=6836144Wed, 01 Jul 2026 21:08:26 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclehttps://investorshangout.com/post/view?id=6835492https://investorshangout.com/post/view?id=6835492Fri, 26 Jun 2026 19:14:48 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in NetworkNewsAudihttps://investorshangout.com/post/view?id=6835489https://investorshangout.com/post/view?id=6835489Fri, 26 Jun 2026 19:05:49 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Edithttps://investorshangout.com/post/view?id=6835357https://investorshangout.com/post/view?id=6835357Thu, 25 Jun 2026 21:04:24 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phhttps://investorshangout.com/post/view?id=6835185https://investorshangout.com/post/view?id=6835185Wed, 24 Jun 2026 20:12:53 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Edithttps://investorshangout.com/post/view?id=6835042https://investorshangout.com/post/view?id=6835042Tue, 23 Jun 2026 22:09:18 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclhttps://investorshangout.com/post/view?id=6834886https://investorshangout.com/post/view?id=6834886Mon, 22 Jun 2026 21:03:22 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerhttps://investorshangout.com/post/view?id=6833018https://investorshangout.com/post/view?id=6833018Mon, 08 Jun 2026 21:30:29 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurologicalhttps://investorshangout.com/post/view?id=6832480https://investorshangout.com/post/view?id=6832480Wed, 03 Jun 2026 20:56:25 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbhttps://investorshangout.com/post/view?id=6832313https://investorshangout.com/post/view?id=6832313Wed, 03 Jun 2026 00:20:40 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Engages Stocks.news for Invhttps://investorshangout.com/post/view?id=6832312https://investorshangout.com/post/view?id=6832312Wed, 03 Jun 2026 00:15:27 GMTNetworkNewsWire: Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’ Disseminated on behahttps://investorshangout.com/post/view?id=6831614https://investorshangout.com/post/view?id=6831614Thu, 28 May 2026 23:31:09 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollmenthttps://investorshangout.com/post/view?id=6830117https://investorshangout.com/post/view?id=6830117Mon, 18 May 2026 20:57:53 GMTAria: Biotech that matters—$QNTM drives impactful innovation in pharmaceuticals, targeting high-value unmehttps://investorshangout.com/post/view?id=6779797https://investorshangout.com/post/view?id=6779797Thu, 31 Jul 2025 16:33:43 GMTAria: $QNTM may be your next winning stock! https://investorshangout.com/post/view?id=6777241https://investorshangout.com/post/view?id=6777241Fri, 18 Jul 2025 18:10:25 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Prevails in Legal Dispute With Former Chttps://investorshangout.com/post/view?id=6755119https://investorshangout.com/post/view?id=6755119Mon, 14 Apr 2025 20:47:16 GMTNetworkNewsWire: NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages Enterprise Canada, Empire Markehttps://investorshangout.com/post/view?id=6744121https://investorshangout.com/post/view?id=6744121Mon, 10 Feb 2025 20:36:10 GMT